Role of γδ T cells in immunity to infectious diseases and the regulation of hematolymphoid cell development

Haas W, Tonegawa S: Gamma/ delta cells. Ann Rev Immunol 1993;1l:637–685. Davis MM: T-cell antigen receptors; in Schwartz BD (ed.): Immunology. Upjohn, Kalamazoo, MI, 1991, pp. 44–61. Schild H, Matvaddat N, Litzenberger C, Ehrich EW, Davis MM, Bluestone JA, et al.: The nature of major histocompatability complex recognition by γδ T-cells. Cell 1994;76:29–37. Sciammas R, Johnson RM, Sperling AI, Brady W, Linsley PS, Spear PG, et al.: Unique antigen recognition by a herpesvirusspecific TCR-γδ cell. J Immunol 1994;152:5392–5397. Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin RL, et al.: Non-peptide ligands for human γδ T-cells. Proc Natl Acad Sci USA 1994;91:8175–8179. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR: Natural and synthetic nonpeptide ligands for human γδ T-cells. Nature 1995;375:155–158. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, Bonneville M, Fournie J-J: Stimulation of human γδ T-cells by nonpeptide mycobacterial ligands. Science 1994;264:267–270. Schoel B, Sprenger S, Kauffman SHE: Phopsphate is essential for stimulation of Vγ9/Vδ2 lymphocytes by mycobacterial low molecular weight ligand. Eur J Immunol 1994;24:1886–1892. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB: Vγ2Vδ2 TCR-dependent recognition of nonpeptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995;154:998–1006. O’Brien RL, Fu Y-X, Cranfill R, Dallas A, Reardon C, Lang J, et al.: HSP60-reactive γδ cells: a large diversified T lymphocyte subset with highly focused specificity. Proc Natl Acad Sci USA 1992;89:4348–4352. Kabelitz D, Pechold K, Bender A: Activation and activation-driven death of human γδ T-cells. Immunol Rev 1991 ;120:71–88. Belles C, Kuhl AL, Donoghue A, Sano Y, O’Brien RL, Born W, et al.: Bias in the γδ T-cell response toListeria monocytogenes. J Immunol 1996; 156:4280–4289. Li B, Rossman MD, Imir T, Oner-Eyuboglu AF, Lee CW, Biancaniello R, Carding SR: Disease-specific changes in γδ T-cell repertoire and function in patients with pulmonary tuberculosis. J Immunol 1996; 157:4222–4229. Doherty PC, Eichelberger M, Allan W, Carding SR: Roles of αΒ and γδ T cell subsets in viral immunity. Ann Rev Immunol 1992; 10:123–151. Carding SR, Allan W, Kyes S, Hayday AC, Bottomly K, Doherty PC: Late dominance of the inflammatory process in murine influenza by γδ+ T-cells. J Exp Med 1990;172:1225–1231. Allan W, Carding SR, Bottomly K, Eichelberger M, Doherty PC: hsp65 mRNA+ macrophages and γδ T-cells in influenza virusinfected mice depleted of the CD4+ and CD8+ lymphocyte subsets. Microb Pathogen 1993; 14:75–84. Eichelberger M, Allan W, Carding SR, Bottomly K, Doherty PC: Activation status of the CD4-CD8-γδ T-cells recovered from mice with influenza pneumonia. J Immunol 1991;147:2069–2074. Hou S, Katz J, Doherty PC, Carding SR: Extent of γδ T-cell involvement in the pneumonia caused by Sendai virus. Cell Immunol 1992; 143:183–193. Doherty PC, Allan W, Eichelberger M, Carding SR: Heat shock proteins and the γδ T-cell response in virus infections. Springer Sem Immunopathol 1991;13:11–24. McVay LD, Carding SR: Extrathymic generation of human γδ T-cells during fetal development. J Immunol 1996;157:2873–2882. McVay LD, Li B, Biancaniello R, Creighton MA, Bachwich D, Lichtenstein G, et al.: Changes in human mucosal γδ T-cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol Med 1997;3:183–203. Carding SR, Jenkinson EJ, Kingston R, Hayday AC, Bottomly K, Owen JJT: Developmental control of lymphokine gene expression in fetal thymocytes during T-cell ontogeny. Proc Natl Acad Sci USA 1989; 86:3342–3345. Carding SR, Reya T: Cytokines in the fetal thymus; in Nikolic-Zugic J (ed): Intrathymic T-Cell Development. RG Landes, Austin, TX, 1994, pp 46–63. Reya T, Yang-Snyder JA, Rothenberg EV, Carding SR: Regulated expression and function of CD122 (Interleukin-2/Intereukin-15R-Β) during lymphoid development. Blood 1996;87:190–201. Horak I, Löhler J, Ma A, Smith KA: Interleukin-2 deficient mice: A new model to study autoimmunity and self-tolerance. Immunol Rev 1995;148:35–43. KrÄmer S, Schimpl A, Hunig T: Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and supression by thymus-depedent cells with and intact IL-2 gene. J Exp Med 1995;182:1769–1776. LÚdvíksson BR, Gray B, Strober W, Ehrhardt RO: Dysregulated intrathymic development in the IL2-deficient mouse leads to colitis-inducing thymocytes. J Immunol 1997;158:104–111. Bassiri H, Egan PJ, Samoilova E, Chen Y, Carding SR: Interleukin 2 (IL2) is required for the induction of thymocyte apoptosis and the elimination of MHC class II-restricted T-cells. 1997, Submitted. Kneitz B, Herrmann T, Yonehara S, Schimpl A: Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol 1995;25: 2572–2577. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253–261. Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, et al.: Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T-cells. Eur J Immunol 1994;25:3053–3059. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995;3:521–530. Suzuki H, Kundig TM, Furlonger C, Wakeman A, Timms E, Matsuyama T, et al.: Deregulated T-cell activation and autoimmunity in mice lacking interleukin-2 receptor Β. Science 1995;268:1472–1476. Contractor NV, Bassiri H, Reya T, Park AV, Baumgart DC, Wasik M, et al.: Lymphoid hyperplasia autoimmunity and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic Interleukin 2-deficient mice. J Immunol 1998; in press. Suzuki H, Duncan GS, Takimoto H, Mak TW: Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL2-receptor Β chain. J Exp Med 1997;185:499–505. Baumgart DC,Rombeau J, Carding SR: Tumor necrosis factor-α and interferon-γ are not cytotoxic for cultured primary murine colonic epithelial cells. 1997, submitted. Reya T, Contractor N, Couzens M, Wasik M, Emerson S, Carding SR: Abnormal myelocytic cell development in interleukin-2 (IL-2)-deficient mice: evidence for the involvement of IL2 in myelopoiesis. Blood 1998; in press. Plaisance S, Rubenstein E, Alileche A, Krief P, Augery-Bourget Y, Sahraoui Y, et al.: Expression of interleukin-2 receptor on human fibroblasts and its biological significance. Int Immunol 1992; 4:739–746. Plaisance S, Rubenstein E, Alileche A, Benoit P, Jasmin C, Azzarone B: The IL2 receptor present on human embryonic fibroblasts is functional in the absence of P64/ IL2Rg chain. Int Immunol 1993; 5:843–848. Weidmann E, Sacchi M, Plaisance S, Seog-Heo D, Yasumura S, Lin WC, et al.: Receptors for interleukin-2 (IL2R) on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res 1992;52:5963–5967. Ciacci C, Mahida R, Dignass A, Koizumi M, Podolsky DK: Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 1993;92:527–532. Frasier-Scott K, Hatzakis H, Seong D, Jones CM, Wu KW: Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. J Clin Invest 1988;82:1877–1883.